Indegene

Indegene was founded in 1998 by Dr. Rajesh Nair, Manish Gupta, Gaurav Kapoor, Dr.Sanjay Parikh and Anand Kiran.^[9] Indegene's first acquisition was Medsn, a company that provided medical education. Medsn continued to operate under the same name in the United States.^[10] In 2008, Medsn officially became known as Indegene Pharmaceutical Solutions in the United States. In 2006, Indegene acquired MedCases, a continuing medical education company based in the United States.^[6][11]

In 2009, Indegene signed a master service agreement with six pharmaceutical companies.^[5][12] The following year, Indegene acquired Canada-based Aptilon, a multichannel marketing firm, for $4 million.^[13] The company subsequently acquired Atlanta-based Total Therapeutic Management in 2014.^[14]

In September 2019, Indegene acquired London-based consulting company, DT Associates, for $10 million.^[15]

In February 2021, the Carlyle Group and Brighton Park Capital invested $200 million in Indegene.^[16] In August 2021, Indegene acquired Medical Marketing Economics (MME), an American market access and pricing strategy company, for $10 million.^[17]

Indegene went public in May 2024 with an initial public offering, raising ₹1,842 crore (US$220 million). It listed on the BSE and the NSE.^[18]

Indegene has offices in India, the United States, the European Union, and Asia-Pacific.^[19][11]

In 2011 and 2012, The Economic Times named Indegene one of the best companies to work for in the Professional Services industry.^[20]

• IQVIA
• Syneos Health